[失眠症状与自杀--联系与处理]。

IF 1.1 Q4 PSYCHIATRY NEUROPSYCHIATRIE Pub Date : 2024-06-01 Epub Date: 2023-05-12 DOI:10.1007/s40211-023-00466-z
Dirk Schwerthöffer, Hans Förstl
{"title":"[失眠症状与自杀--联系与处理]。","authors":"Dirk Schwerthöffer, Hans Förstl","doi":"10.1007/s40211-023-00466-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A link between insomniac symptoms and suicidality has long been suspected and deserves specific attention.</p><p><strong>Objective: </strong>We examine the current evidence for this relationship from epidemiology and neurobiology in order to propose a targeted management.</p><p><strong>Material and method: </strong>Clinical example and selective Medline-literature research for insomnia symptoms and suicidality.</p><p><strong>Results: </strong>Epidemiological data and statistical analysis show that symptoms of insomnia are independent risk factors for suicidality. Neurobiological factors associated with combined insomnia symptoms and suicidality are: serotonergic dysfunction and circadian rhythm disorder leading to hypofrontality with reduced problem solving capacity and impaired emotional and impulse-control. Social isolation, recurrent rumination, comorbid psychiatric disorders, access to potentially lethal drugs or weapons need urgent evaluation in patients with a combination of suicidality and symptoms of insomnia.</p><p><strong>Conclusion: </strong>patients with insomnia and further risk factors for suicide need to be treated resolutely and at an early stage. Modern sleep-promoting antidepressants with low toxicity and antipsychotics must be preferred in the treatment of patients with insomniac sleep disorders and suicidality. Multimodal anti-insomnia and anti-depressive therapy adapted to the circadian rhythm can exert a favorable influence both on depressive-suicidal and insomnia symptoms and their inherent risks.</p>","PeriodicalId":44560,"journal":{"name":"NEUROPSYCHIATRIE","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11143018/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Insomniac symptoms and suicidality-link and management].\",\"authors\":\"Dirk Schwerthöffer, Hans Förstl\",\"doi\":\"10.1007/s40211-023-00466-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>A link between insomniac symptoms and suicidality has long been suspected and deserves specific attention.</p><p><strong>Objective: </strong>We examine the current evidence for this relationship from epidemiology and neurobiology in order to propose a targeted management.</p><p><strong>Material and method: </strong>Clinical example and selective Medline-literature research for insomnia symptoms and suicidality.</p><p><strong>Results: </strong>Epidemiological data and statistical analysis show that symptoms of insomnia are independent risk factors for suicidality. Neurobiological factors associated with combined insomnia symptoms and suicidality are: serotonergic dysfunction and circadian rhythm disorder leading to hypofrontality with reduced problem solving capacity and impaired emotional and impulse-control. Social isolation, recurrent rumination, comorbid psychiatric disorders, access to potentially lethal drugs or weapons need urgent evaluation in patients with a combination of suicidality and symptoms of insomnia.</p><p><strong>Conclusion: </strong>patients with insomnia and further risk factors for suicide need to be treated resolutely and at an early stage. Modern sleep-promoting antidepressants with low toxicity and antipsychotics must be preferred in the treatment of patients with insomniac sleep disorders and suicidality. Multimodal anti-insomnia and anti-depressive therapy adapted to the circadian rhythm can exert a favorable influence both on depressive-suicidal and insomnia symptoms and their inherent risks.</p>\",\"PeriodicalId\":44560,\"journal\":{\"name\":\"NEUROPSYCHIATRIE\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11143018/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NEUROPSYCHIATRIE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40211-023-00466-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/5/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEUROPSYCHIATRIE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40211-023-00466-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:长期以来,人们一直怀疑失眠症状与自杀之间存在联系,这一点值得特别关注:长期以来,人们一直怀疑失眠症状与自杀之间存在联系,这一点值得特别关注:我们从流行病学和神经生物学角度研究了这一关系的现有证据,以便提出有针对性的管理建议:材料与方法:针对失眠症状和自杀倾向的临床实例和选择性 Medline 文献研究:结果:流行病学数据和统计分析显示,失眠症状是自杀的独立风险因素。与合并失眠症状和自杀相关的神经生物学因素有:血清素能失调和昼夜节律紊乱,导致前额叶功能减退,解决问题的能力降低,情绪和冲动控制能力受损。对于合并有自杀倾向和失眠症状的患者,需要对其社会隔离、反复反刍、合并精神障碍、获得潜在致命药物或武器的机会进行紧急评估。在治疗失眠睡眠障碍和自杀倾向患者时,必须首选毒性低的现代促进睡眠抗抑郁药物和抗精神病药物。适应昼夜节律的多模式抗失眠和抗抑郁疗法可对抑郁自杀和失眠症状及其固有风险产生有利影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Insomniac symptoms and suicidality-link and management].

Background: A link between insomniac symptoms and suicidality has long been suspected and deserves specific attention.

Objective: We examine the current evidence for this relationship from epidemiology and neurobiology in order to propose a targeted management.

Material and method: Clinical example and selective Medline-literature research for insomnia symptoms and suicidality.

Results: Epidemiological data and statistical analysis show that symptoms of insomnia are independent risk factors for suicidality. Neurobiological factors associated with combined insomnia symptoms and suicidality are: serotonergic dysfunction and circadian rhythm disorder leading to hypofrontality with reduced problem solving capacity and impaired emotional and impulse-control. Social isolation, recurrent rumination, comorbid psychiatric disorders, access to potentially lethal drugs or weapons need urgent evaluation in patients with a combination of suicidality and symptoms of insomnia.

Conclusion: patients with insomnia and further risk factors for suicide need to be treated resolutely and at an early stage. Modern sleep-promoting antidepressants with low toxicity and antipsychotics must be preferred in the treatment of patients with insomniac sleep disorders and suicidality. Multimodal anti-insomnia and anti-depressive therapy adapted to the circadian rhythm can exert a favorable influence both on depressive-suicidal and insomnia symptoms and their inherent risks.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
NEUROPSYCHIATRIE
NEUROPSYCHIATRIE PSYCHIATRY-
CiteScore
3.80
自引率
20.00%
发文量
31
期刊介绍: Die Zeitschrift ist das offizielle Organ der „Österreichischen Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik (ÖGPP)'', und wissenschaftliches Organ der Österreichischen Alzheimer Gesellschaft, der Österreichischen Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, der Österreichischen Schizophreniegesellschaft, und der pro mente austria - Österreichischer Dachverband der Vereine und Gesellschaften für psychische und soziale Gesundheit.Sie veröffentlicht Übersichten zu relevanten Themen des Fachs, Originalarbeiten, Kasuistiken sowie Briefe an die Herausgeber. Zudem wird auch Buchbesprechungen sowie Neuigkeiten aus den Bereichen Personalia, Standes- und Berufspolitik sowie Kongressankündigungen Raum gewidmet.Thematisch ist das Fach Psychiatrie und die Methoden der Psychotherapie in allen ihren Facetten vertreten. Die Zeitschrift richtet sich somit an alle Berufsgruppen, die sich mit Ursachen, Erscheinungsformen und Behandlungsmöglichkeiten von psychischen Störungen beschäftigen.  -----------------------------------------------------------------------------------------------------·        The professional and educational journal of the Austrian Society of Psychiatry, Psychotherapy and Psychosomatics (Österreichische Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik; ÖGPP) and the Austrian Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (Österreichische Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie; ÖGKJP)·        Overviews of all relevant topics pertaining to the discipline·        Intended for all occupational groups committed to the causes and manifestations of, as well as therapy options for psychic disorders·        All manuscripts principally pass through a double-blind peer review process involving at least two independent expertsThe official journal of the Austrian Societies of Psychiatry, Psychotherapy and Psychosomatics (ÖGPP) and Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (ÖGKJP)The journal publishes overviews of relevant issues in the field, original work, case reports and letters to the editors. In addition, space is devoted to book reviews, news from the areas of personnel matters and professional policies, and conference announcements.Thematically, the discipline of psychiatry and the methods of psychotherapy are represented in all their facets. The journal is thus aimed at all professional groups committed to the causes and manifestations of, as well as therapy options for psychic disorders
期刊最新文献
kultur im kontext. [Therapy strategies for repetitive vocalizations in dementia : A systematic review]. [Violence in contact and custody proceedings-A case of child endangerment in the family court-Where are efficient child protection measures?] Gender differences in neurocognitive assessments: insights from a pilot study with the International Neurocognitive Test Profile (INCP) digital battery. Can cerebrospinal fluid biomarkers tell us something about financial capacity in Alzheimer's disease patients? A preliminary study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1